RxDoctor Payments Data

Brian Curtin, DO

Interventional Pain Medicine · Glendale, WINPI 1093001851

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.8% of the total across 33 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Medtronic at 34.5% of the total. That places this record below the midpoint for interventional pain medicine clinicians in WI, where the typical reported total is $2,684.

$1,688in general payments, 2019–2025

Across 33 payments — averaging $51.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$583
  • Nevro Corp.$308
  • Saluda Medical Americas, Inc.$139
  • Boston Scientific$136
  • Si-bone, Inc.$135
  • GRT US Holding, Inc.$115
  • plus $272 from 9 others

What the payments were for

  • Travel & lodging$40%
  • Food & beverage$1,684100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,688 in reported general payments places this provider in the 40th percentile of 41 interventional pain medicine providers in Wisconsin.

See all interventional pain medicine providers in Wisconsin

Medicare billing

Part B allowed, 2024
$56,791
Medicare patients
159
Services billed
900

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl17$9,539
Gabapentin174$2,403
Buprenorphine14$2,302
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen109$1,811
Pregabalin81$1,382
Tramadol Hcl91$1,067
Tizanidine Hcl73$725
Oxycodone Hcl29$522
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen25$496
Topiramate33$382
Duloxetine Hcl30$269
Meloxicam98$151
Baclofen22$144

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Glendale

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →